GLP-I protected amino acidum latus catenam modificationem
Product Detail
| Non. | Productus | Cas No. | Applicatio | Key species indicator | ||||
| Pudicitia | Isomer | Si * | Max * | Humor | ||||
| 1 | Fmoc, Lys (MTT) -OH | 167393-62-6 | Lysine latus catenam modificationem | ≥99.0% | ≤0.1% | ≤0.2% | ≤0.3% | ≤1.0% |
| 2 | Fmoc, lys (Alloc) -oh | 146982-27-6 | Lysine latus catenam modificationem | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 3 | Fmoc, lys (ivdde) -ohh | 150629-67-7 | Lysine latus catenam modificationem | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 4 | Fmoc, lys (MMT) -ohh | 159857-60-0 | Lysine latus catenam modificationem | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 5 | Fmoc, glu-otbu | 84793-07-7 | LiraglutideSemaglutide | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 6 | Glu, otbu | 45120-30-7 | LiraglutideSemaglutide | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 7 | Acidum octadecapedioic | 871-70-5 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 8 | Octadecapedioic Acidum Mono-Tert, Butyl Ester | 843666-40-0 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 9 | TBU-OOC, C16, Co-GLU, Otbu | 1188328-39-3 | SemaglutideFragmentum est | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 10 | AEA | 134978-97-5 | SemaglutideAlbuvirtide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 11 | Aeea, oh.hcl | 134979-01-4 | SemaglutideAlbuvirtide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 12 | Fmoc, AEEA, O | 166108-71-0 | SemaglutideAlbuvirtide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 13 | Boc, AEEA, O | 108466-89-3 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 14 | AEEA, AEEA | 1143516-05-5 | Semaglutide | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 15 | Fmoc, AEEA, AEEA, O | 560088-89-3 | SemaglutideB Dragment | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 16 | Octa (otbu) -glu (ɑ-otbu) -aeea, aeea-oh | 1118767-16-0 | SemaglutideFragmentum C | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 17 | TBU-OOC, C16, Co-GLU (AEEA, AEEA, NHS) -otbu | 1118767-15-9 | SemaglutideD Fragmentum | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 18 | Fmoc, lys (TBU-OOC, C16, Co-GLU (AEEA, AEEA) -otbu) -Oh | 1662688-20-1 | SEMAGLUTIDE Fragmentum E | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 19 | Boc, eius (TT) -OH | 32926-43-5 | Finis est histidine | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤4.0% |
| 20 | FMOC-AIB, O | 94744-50-0 | Semaglutide | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 21 | Boc, eius (TRT) -AB-O | 2061897-68-3 | Semaglutide | ≥99.0% | ≤0.1% | ≤0.2% | ≤0.3% | ≤2.0% |
| 22 | Fmoc, glu (otbu) -gly-o | 866044-63-5 | GLP, I analoge | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 23 | Boc, eius (TRT) -AB-GLU (otbu) -gly-O | 1169630-31-2? | Semaglutide Fragment F | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 24 | Boc, eius (TRT) -AB-GLU (otbu) -gly-NHS | 1169630-40-3 | Semaglutide fragmentum G | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 25 | Fmoc, Arg (PBF) -gly-O | 660846-80-0 | GLP, I analoge | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 26 | FMOC-Ala, Ala | 87512-31-0 | GLP, I analoge | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 27 | Fmoc, Thr (TBU) -Pe-O | 1260609-75-3? | GLP, I analoge | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 28 | Acidum palmitic | 1957/10/3 | Liraglutide fragmentum I | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 29 | Palm-glu-otbu | NA | Liraglutide fragmentum II | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 30 | Palm-GLU (nes) -otbu | NA | Liraglutide fragmentum III | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 31 | Fmoc, lys (Palm-glu-otbu) -oh | 1491158-62-3 | Liraglutide | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 32 | Acidum hexadecanenarioic | 505-54-4 | Insulin degludec | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 33 | Hexadecanenarioic acidum mono-Tert, butyl Ester | 843666-27-3 | Insulin degludec | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 34 | TBU-OOC, C14, Co-GLU, Otbu | NA | Insulin Degludec fragmentis i | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 35 | TBU-OOC, C14, Co-GLU (NES) -otbu | NA | Insulin Degludec fragmentum II | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
Si * = specifica immunditiam
Max * = max ignotus immunditiam
Alius indicator:
- Acidum acetic: ≤0.02% (omnes products)
- Ethyl acetate: ≤0.5% (omnes products)
- Vocatus: ≤0.5% (omnes products)
Sanitization
Sanitization distribution ratio, comprehendo loop et repono tristique quod per pasteurization. Cum pasteurization sanitization fit, purificatum aquam in piscinam est calefacta usque ad LXXX ° C et satus ad circulari per distribution ratio. Et Sanitization Last I hora postquam ad LXXX ° c. Sanitization fit omnis quarta. Purificati aqua ratio Sanitization Lypo erat sedatus nihil peregrinandum fert.
